T
0.010
0.00 (0.00%)
| Penutupan Terdahulu | 0.010 |
| Buka | 0.010 |
| Julat 52 Minggu |
| Margin Keuntungan | -267.41% |
| Margin Operasi (TTM) | -328.48% |
| EPS Cair (TTM) | -30.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -61.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 420.52% |
| Nisbah Semasa (MRQ) | 1.23 |
| Aliran Tunai Operasi (OCF TTM) | -22.87 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -10.21 M |
| Pulangan Atas Aset (ROA TTM) | -30.10% |
| Pulangan Atas Ekuiti (ROE TTM) | -178.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Telesis Bio, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.1 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 0.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -4.2 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -1.27 |
|
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 4.64% |
| % Dimiliki oleh Institusi | 30.00% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |